Shuhang J. Zhang

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Value of dual-energy CT in assessing therapeutic response after TACE for hepatocellular carcinoma: A retrospective comparative study with conventional CT.

Value of dual-energy CT in assessing therapeutic response after TACE for hepatocellular carcinoma: A retrospective comparative study with conventional CT.

Journal: European journal of radiology

Published: May 13, 2026

Preoperative CT detection of appendiceal neoplasms in suspected acute appendicitis using a simple diameter-and-fecalith criterion: multicenter derivation and validation.

Preoperative CT detection of appendiceal neoplasms in suspected acute appendicitis using a simple diameter-and-fecalith criterion: multicenter derivation and validation.

Journal: European journal of radiology

Published: April 17, 2026

MR Radiomics Combined With Radiologic Features to Predict Recurrence Location in Nonviable Hepatocellular Carcinoma After Transarterial Chemoembolization.

MR Radiomics Combined With Radiologic Features to Predict Recurrence Location in Nonviable Hepatocellular Carcinoma After Transarterial Chemoembolization.

Journal: Journal of gastroenterology and hepatology

Published: November 20, 2025

MRI-Based Score to Predict Retreatment Response for Viable Hepatocellular Carcinomas After Transarterial Chemoembolization.

MRI-Based Score to Predict Retreatment Response for Viable Hepatocellular Carcinomas After Transarterial Chemoembolization.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 18, 2025

Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients.

Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients.

Journal: JAMA network open

Published: June 10, 2025

Characteristics of cardiac lesions in 17 patients with Fabry disease

Characteristics of cardiac lesions in 17 patients with Fabry disease

Journal: Zhonghua xin xue guan bing za zhi

Published: May 19, 2025

The nVR model: prediction of LI-RADS treatment response nonviable recurrence of hepatocellular carcinoma after primary transarterial chemoembolization.

The nVR model: prediction of LI-RADS treatment response nonviable recurrence of hepatocellular carcinoma after primary transarterial chemoembolization.

Journal: Abdominal radiology (New York)

Published: February 08, 2025

Transient hepatic intensity differences: correlations with treatment outcomes and adverse events following DEB-TACE in hepatocellular carcinoma.

Transient hepatic intensity differences: correlations with treatment outcomes and adverse events following DEB-TACE in hepatocellular carcinoma.

Journal: Insights into imaging

Published: February 07, 2025

LI-RADS Nonradiation Treatment Response Algorithm Version 2024: Diagnostic Performance and Impact of Ancillary Features.

LI-RADS Nonradiation Treatment Response Algorithm Version 2024: Diagnostic Performance and Impact of Ancillary Features.

Journal: AJR. American journal of roentgenology

Published: November 13, 2024

Dynamic changes of radiological and radiomics patterns based on MRI in viable hepatocellular carcinoma after transarterial chemoembolization.

Dynamic changes of radiological and radiomics patterns based on MRI in viable hepatocellular carcinoma after transarterial chemoembolization.

Journal: Abdominal radiology (New York)

Published: September 14, 2024

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma.

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: September 11, 2024

Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis.

Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis.

Journal: Abdominal radiology (New York)

Published: October 17, 2023

Showing 1-12 of 13

Last Updated: 09/26/2026